MétaCan
← all works

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

2016· article· en· 372 citations· W2512442926 on OpenAlex· 10.1038/nchembio.2166

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.005
GPT teacher head0.252
Teacher spread
0.247 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.

The record

Venue
Nature Chemical Biology
Topic
Protein Degradation and Inhibitors
Field
Biochemistry, Genetics and Molecular Biology
Canadian institutions
Funders
National Cancer InstituteMedical Research CouncilMinistero dello Sviluppo EconomicoOntario Genomics InstituteHope Funds for Cancer ResearchDiamond Light SourceNational Human Genome Research InstituteWellcome TrustNational Institutes of HealthOntario GenomicsGenome CanadaOntario Ministry of Economic Development and InnovationKoch Institute for Integrative Cancer Research, Massachusetts Institute of TechnologyDeutsche ForschungsgemeinschaftDana-Farber/Harvard Cancer CenterGlaxoSmithKlinePfizerEli Lilly and Company
Keywords
KinaseEnhancerCell biologyBiologyTranscription factorCyclin-dependent kinaseProcessivityGene expressionTranscription (linguistics)GeneChemistryMolecular biologyGeneticsPolymeraseCell cycle
Has abstract in OpenAlex
no